• Home
  • PR

PR

News

게시물 상세
OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate
Date : 2021-02-15     View : 689

OliX Pharmaceuticals Announces Results from Preclinical Study of Hair Loss Therapeutic Candidate

 

-Company to discuss study results and present corporate overview at SMi’s 12th Annual RNA Therapeutics Virtual Conference on February 11

 

Learn more: https://finance.yahoo.com/news/olix-pharmaceuticals-announces-results-preclinical-224500236.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAAMQtHyfkE6IVOsaBOYZA_3ULzo0sa5RZtNJTu41quN_r_lLy9ejTv3Teh24aKw-ByxcvNk6omZFnHLBgIhN5Lmmnzmx6lfVN9vzvRAGfSysELRWbd2VQgi4HA2a7LeJfiLDbk8epS79Z-vaEn7yERvdtJNKgZlYIgR4pQABxRY_U

 

Source _ OliX Pharmaceuticals

Prev OliX and PCI Biotech Announce a Collaboration to Combine Technologies
Next OliX Pharmaceuticals Launches New Subsidiary to Develop mRNA Vaccines and Therapeutics